We are live on
!
Find out more
PG
Prostatis Group Portfolio holdings
AUM
$391M
1-Year Est. Return
20.37%
This Fund
S&P 500
This Quarter
Est. Return
+4.78%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$25.5M
(+13%)
Cap. Flow
+$7.11B
Cap. Flow
% of AUM
3,306.68%
Top 10 Holdings %
Top 10 Hldgs %
45.2%
Holding
253
New
155
Increased
83
Reduced
10
Closed
3
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$782M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$460M |
| 3 |
Home Depot
HD
|
+$381M |
| 4 |
Amplify CWP Enhanced Dividend Income ETF
DIVO
|
+$363M |
| 5 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
+$330M |
Top Sells
| 1 |
iShares US Healthcare Providers ETF
IHF
|
+$8.63M |
| 2 |
State Street SPDR S&P Semiconductor ETF
XSD
|
+$615K |
| 3 |
ARK Autonomous Technology & Robotics ETF
ARKQ
|
+$441K |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$411K |
| 5 |
Prospect Capital
PSEC
|
+$324K |
Sector Composition
| 1 | Technology | 3.03% |
| 2 | Industrials | 2.47% |
| 3 | Consumer Staples | 1.65% |
| 4 | Financials | 1.63% |
| 5 | Consumer Discretionary | 1.62% |
Similar funds
S
RI
CFA
SI
MA
TCM
IPW
HP
Prostatis Group's Q2 2023 Portfolio in Review
As of Q2 2023, Prostatis Group held 253 positions worth $215M, up 13% from $189M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Prostatis Group deployed $7.11B of net new capital in Q2 2023, opening 155 new positions and adding to 83 existing holdings. Its largest new stake was 3M: 967,937 shares worth $847K.
By sector, the portfolio is most concentrated in Technology at 3% of assets, up from 2.4% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was State Street SPDR S&P Semiconductor ETF, an estimated $615K trimmed.
- Prostatis Group's largest Q2 2023 buy was 3M: 967,937 shares worth $847K.
- Prostatis Group added most to Thermo Fisher Scientific in Q2 2023, an estimated $782M increase.
- Prostatis Group's biggest Q2 2023 reduction was State Street SPDR S&P Semiconductor ETF, cutting an estimated $615K.
- Prostatis Group fully exited iShares US Healthcare Providers ETF in Q2 2023, selling an estimated $8.63M.
- Prostatis Group's ten largest holdings make up 45% of its $215M portfolio in Q2 2023.
- Prostatis Group opened 155 new positions and closed 3 in Q2 2023.
- Prostatis Group's portfolio value rose 13% quarter-over-quarter to $215M.
Based on Prostatis Group's 13F filing for Q2 2023, filed 14 Aug 2023.